↓ Skip to main content

Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer – PARC: study…

Overview of attention for article published in BMC Cancer, October 2005
Altmetric Badge

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer – PARC: study protocol [ISRCTN56652283]
Published in
BMC Cancer, October 2005
DOI 10.1186/1471-2407-5-131
Pubmed ID
Authors

R Krempien, MW Muenter, PE Huber, S Nill, H Friess, C Timke, B Didinger, P Buechler, S Heeger, KK Herfarth, A Abdollahi, MW Buchler, J Debus

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
United Kingdom 1 2%
China 1 2%
Germany 1 2%
Unknown 46 92%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 20%
Researcher 9 18%
Student > Master 7 14%
Student > Bachelor 5 10%
Librarian 2 4%
Other 8 16%
Unknown 9 18%
Readers by discipline Count As %
Medicine and Dentistry 21 42%
Agricultural and Biological Sciences 4 8%
Biochemistry, Genetics and Molecular Biology 3 6%
Physics and Astronomy 3 6%
Nursing and Health Professions 2 4%
Other 5 10%
Unknown 12 24%